Schedule 13G ownership disclosure

Avalo Therapeutics, Inc.

Class A Common Stock · CUSIP: 05338F306

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • SilverArc Capital Management, LLC

    Shares: 720,922.00 · Class: 5.48%

  • Devesh Gandhi

    Shares: 720,922.00 · Class: 5.48%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-112178
Form type
SCHEDULE 13G
Filer
Avalo Therapeutics, Inc.
CIK
CIK 1534120
Filed
Nov 14, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub